Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Agyrax
2. Antivert
3. Bonamine
4. Bonine
5. Chiclida
6. D Vert
7. D-vert
8. Dihydrochloride, Meclizine
9. Dvert
10. Histametizyn
11. Hydrochloride, Meclizine
12. Meclizine
13. Meclizine Dihydrochloride
14. Meclizine Hydrochloride
15. Meclizine Monohydrochloride
16. Meclozine
17. Monohydrochloride, Meclizine
18. Parachloramine
19. Ru Vert M
20. Ru-vert-m
1. Meclizine Hydrochloride
2. Meclizine Dihydrochloride Monohydrate
3. 31884-77-2
4. Postafen
5. Agyrax
6. Bonamine
7. Hdp7w44cio
8. Meclozine Hydrochloride Monohydrate
9. Ucb-5062
10. 1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine;hydrate;dihydrochloride
11. Nsc-757094
12. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-, Dihydrochloride, Monohydrate
13. Mfcd00941489
14. Meclizine Hcl Hydrate
15. Nsc-28728
16. Unii-hdp7w44cio
17. Antivert (tn)
18. Chembl3989555
19. Chebi:31805
20. Dtxsid30953792
21. Meclizine Hydrochloride (jan/usp)
22. Meclizine Hydrochloride [usp:jan]
23. Bcp13363
24. Meclizine Hydrochloride [jan]
25. Meclizine Hydrochloride [vandf]
26. Nsc 757094
27. 1-(p-chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)piperazine Dihydrochloride Monohydrate
28. Meclizine Hydrochloride [usp-rs]
29. As-13740
30. Meclizine Hydrochloride [orange Book]
31. D01317
32. Meclizine Hydrochloride [usp Monograph]
33. A821043
34. Meclizine Dihydrochloride Monohydrate [mi]
35. (+/-)-meclizine Dihydrochloride Monohydrate
36. Meclozine Hydrochloride Monohydrate [who-dd]
37. Meclizine Dihydrochloride Monohydrate, (+/-)-
38. Q27279880
39. 1-((4-chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine Dihydrochloride Hydrate
40. 1-((4-chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazinedihydrochloridehydrate
41. 1-(p-chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl) Piperazine Dihydrochloride Monohydrate
42. 1-(p-chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)piperazine Dihydrochloride Monohydrate
43. 1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine--hydrogen Chloride--water (1/2/1)
44. 1-[(4-chlorophenyl)-phenyl-methyl]-4-(m-tolylmethyl)piperazine Hydrate Dihydrochloride;meclizine Dihydrochloride Monohydrate
45. 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine Dihydrochloride Hydrate
Molecular Weight | 481.9 g/mol |
---|---|
Molecular Formula | C25H31Cl3N2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 480.150197 g/mol |
Monoisotopic Mass | 480.150197 g/mol |
Topological Polar Surface Area | 7.5 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 448 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
1 of 1 | |
---|---|
Drug Name | MECLIZINE HYDROCHLORIDE |
Active Ingredient | MECLIZINE HYDROCHLORIDE |
Company | AMNEAL PHARMS (Application Number: A201451); EPIC PHARMA LLC (Application Number: A200294); JUBILANT CADISTA (Application Number: A040659); MYLAN PHARMS INC (Application Number: A202640); PAR PHARM (Application Number: A087127); PAR PHARM (Application Number: A087128); SANDOZ (Application Number: A084092); SANDOZ (Application Number: A084843) |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Cholinergic Antagonists
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Suspension
Grade : Oral
Brand Name : Acesulfame Potassium
Application : Taste Masking
Dosage Form : Tablet
Grade : Oral
Dosage Form : Syrup
Grade : Oral
Application : Taste Masking
Dosage Form : Syrup
Grade : Oral
Application : Fillers, Diluents & Binders
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : Mannitol is mainly used as a bulking agent in tableting. It is also used as taste masking agent in ODT formulations.
Dosage Form : Suspension
Grade : Oral
Dosage Form : Suspension
Grade : Oral
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?